Liabilities, Current of HilleVax, Inc. from 31 Dec 2021 to 30 Jun 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
- Summary
-
HilleVax, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2021 to 30 Jun 2025.
- HilleVax, Inc. Liabilities, Current for the quarter ending 30 Jun 2025 was $6,147,000, a 87% decline year-over-year.
- Source SEC data
- View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)
HilleVax, Inc. Quarterly Liabilities, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | $6,147,000 | -$43,018,000 | -87% | 30 Jun 2025 | 10-Q | 06 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $6,545,000 | -$19,204,000 | -75% | 31 Mar 2025 | 10-Q | 08 May 2025 | 2025 | Q1 |
| Q4 2024 | $16,455,000 | -$12,811,000 | -44% | 31 Dec 2024 | 10-Q | 06 Aug 2025 | 2025 | Q2 |
| Q3 2024 | $13,836,000 | -$5,122,000 | -27% | 30 Sep 2024 | 10-Q | 07 Nov 2024 | 2024 | Q3 |
| Q2 2024 | $49,165,000 | +$30,827,000 | +168% | 30 Jun 2024 | 10-Q | 09 Aug 2024 | 2024 | Q2 |
| Q1 2024 | $25,749,000 | +$6,476,000 | +34% | 31 Mar 2024 | 10-Q | 09 May 2024 | 2024 | Q3 |
| Q4 2023 | $29,266,000 | +$16,220,000 | +124% | 31 Dec 2023 | 10-K | 28 Mar 2025 | 2024 | FY |
| Q3 2023 | $18,958,000 | +$10,325,000 | +120% | 30 Sep 2023 | 10-Q | 09 Nov 2023 | 2023 | Q3 |
| Q2 2023 | $18,338,000 | +$5,828,000 | +47% | 30 Jun 2023 | 10-Q | 14 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $19,273,000 | -$263,653,000 | -93% | 31 Mar 2023 | 10-Q | 12 May 2023 | 2023 | Q1 |
| Q4 2022 | $13,046,000 | -$214,716,000 | -94% | 31 Dec 2022 | 10-K | 20 Mar 2024 | 2023 | FY |
| Q3 2022 | $8,633,000 | 30 Sep 2022 | 10-Q | 10 Nov 2022 | 2022 | Q3 | ||
| Q2 2022 | $12,510,000 | 30 Jun 2022 | 10-Q | 10 Aug 2022 | 2022 | Q2 | ||
| Q1 2022 | $282,926,000 | 31 Mar 2022 | 10-Q | 08 Jun 2022 | 2022 | Q1 | ||
| Q4 2021 | $227,762,000 | 31 Dec 2021 | 10-K | 17 Mar 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.